Osmotic Pump Tablet Coating for Consistent Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing oral drug delivery systems fail to provide prolonged and steady plasma profiles for active pharmaceutical ingredients with absorption windows limited to the upper gastrointestinal tract, and existing osmotic pump tablets struggle with drug residue and inconsistent release due to structural limitations.
Innovation Solution
A controlled-release system comprising a pharmaceutical composition with a tablet core and coating membrane, using cellulose acetate and copovidone, and a retention enabling platform that maintains the tablet in the oral cavity, combined with a personalized oral retention device that fits securely to the teeth, ensuring consistent drug delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional extended-release dosages are used, then the dosage form is simple and easy to manufacture, but the bioavailability is compromised and therapeutic coverage is not prolonged
Solution Approach 1:
The patent embeds the osmotic pump tablet within a retention device structure. The tablet is positioned inside a cavity formed by opposing walls, with the retention device acting as a container that holds the tablet in place. This nested configuration allows the tablet to remain in the oral cavity during swallowing, enabling prolonged exposure to the absorption window while maintaining simple manufacturing through injection molding of the retention device.
Solution Approach 2:
The patent incorporates a coating layer on the tablet surface that is prepared in advance during tablet formation. This coating, composed of hydrophilic polymer and osmotic agent, is applied before the tablet is placed in the retention device, enabling controlled water penetration and osmotic drug release to begin immediately upon contact with saliva, thus ensuring prolonged and reliable bioavailability.
2Duration of action of moving object
If the tablet is placed in the oral cavity for prolonged exposure, then the drug absorption window is extended, but the tablet may be accidentally swallowed or lost
Solution Approach 1:
The tablet is nested within a retention device that features a cavity bounded by opposing walls. The retention device acts as a protective container that physically secures the tablet in place during the prolonged exposure period, preventing accidental swallowing or loss while maintaining the necessary drug absorption window.
Solution Approach 2:
The patent introduces a retention device as an intermediary between the tablet and the oral environment. This device mediates the interaction by providing a secure mounting structure that holds the tablet in position, enabling prolonged exposure without the risk of accidental swallowing, while the coating layer continues to mediate the drug release process.
3Productivity
If existing osmotic pump tablets are used, then the drug release mechanism is established, but structural limitations cause drug residue and inconsistent release
Solution Approach 1:
The patent applies a specific coating layer composition (hydrophilic polymer and osmotic agent in defined ratios) to the tablet surface, creating localized functional zones that control water penetration and osmotic pressure. This local quality enhancement ensures consistent drug release by optimizing the interface between the tablet and oral environment, eliminating drug residue while maintaining reliable release kinetics.
Solution Approach 2:
The patent modifies the coating layer parameters by controlling the ratios of hydrophilic polymer to osmotic agent (e.g., 1:0.1 to 1:10 by weight). These parameter adjustments optimize the osmotic pressure and water penetration rate, ensuring consistent and complete drug release without residue, thereby improving productivity while eliminating substance loss.
4Reliability
If a retention device is added to hold the tablet, then the tablet can be retained in the oral cavity, but the device complexity increases
Solution Approach 1:
The retention device is constructed using thin-walled structures formed by injection molding. The opposing walls create a cavity that securely holds the tablet, while the thin film construction minimizes material usage and device complexity. This approach achieves reliable retention capability through geometric design rather than complex mechanical mechanisms.
Solution Approach 2:
The retention device serves multiple functions simultaneously: it holds the tablet in place during prolonged exposure, prevents accidental swallowing, and provides a mounting structure for the coating layer. This multi-functionality reduces the need for additional separate components, thereby maintaining device simplicity while achieving reliable retention capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system achieves prolonged drug exposure and steady plasma profiles by maintaining the tablet in the oral cavity, preventing accidental swallowing, and ensuring complete drug release without residue, even for poorly water-soluble drugs.
Implementation Method 1
When in an aqueous environment, water enters the tablet core through the semipermeable controlled-release membrane, hydrating the tablet core to generate a drug solution, resulting in a difference in internal and external osmotic pressure. Driven by the osmotic pressure difference, water continuously enters the tablet core through the semipermeable coating membrane, driving the drug solution to be released from the drug-release orifice.
Implementation Method 2
a coating membrane, wherein the tablet core comprises a drug-containing layer, and the coating membrane comprises cellulose acetate and copovidone
Data Source
AI summary
The present disclosure relates to an osmotic pump tablet, preparation method therefor and use thereof. The osmotic pump tablet comprises a tablet core and a coating membrane that wraps around the tablet core, with a drug-release orifice in the coating membrane. The tablet core includes a drug-containing layer, which contains an active pharmaceutical ingredient, a hydrophilic polymer, and a surfactant. The hydrophilic polymer includes hydroxypropyl cellulose, and the surfactant includes poloxamer; or the drug-containing layer contains an active pharmaceutical ingredient and a hydrophilic polymer, but no surfactant. The hydrophilic polymer includes povidone K29/32; or the osmotic pump tablet includes a drug-containing immediate release overcoat, which contains an active pharmaceutical ingredient and a pharmaceutical excipient, which is a binding agent. The osmotic pump tablet disclosed herein features high drug loading capacity, enabling it to achieve optimal therapeutic efficacy.